Stocks and Investing Stocks and Investing
Wed, August 16, 2023
Tue, August 15, 2023

Joseph Catanzaro Initiated (tsbx) at Buy and Held Target at $20 on, Aug 15th, 2023


Published on 2024-10-28 05:55:55 - WOPRAI, Joseph Catanzaro
  Print publication without navigation


Joseph Catanzaro of Piper Sandler, Initiated "Turnstone Biologics Corp." (TSBX) at Buy and Held Target at $20 on, Aug 15th, 2023.

Joseph, nor any peers, have made any analyst calls on TSBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources